Aandelen in “Medische/verpleegkundige diensten”

Aandeel Datum Koers Evolutie
vlag Forte Biosciences Inc 19/05 20,070 USD
-4,29% 		-4,29%
vlag Fresenius Medical Care AG & Co. KGaA 19/05 38,340 EUR
+0,58% 		+0,58%
vlag Fresenius Medical Care AG & Co. KGaA 19/05 22,100 USD
-0,54% 		-0,54%
vlag Fulgent Genetics Inc 19/05 15,950 USD
+0,63% 		+0,63%

Nieuws over “Medische/verpleegkundige diensten”

13/05 · Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference · Persbericht

13/05 · Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference · Persbericht

12/05 · Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation · Persbericht

7/05 · RAMSAY SANTE : Unaudited interim results at end March 2026 · Persbericht

7/05 · DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference · Persbericht

6/05 · Castle Biosciences Reports First Quarter 2026 Results · Persbericht

6/05 · Option Care Health Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Option Care Health (OPCH) · Persbericht

5/05 · DaVita Inc. 1st Quarter 2026 Results · Persbericht

5/05 · Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline · Persbericht

5/05 · Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed · Persbericht

5/05 · Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month · Persbericht

4/05 · New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett's Esophagus · Persbericht

29/04 · Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025 · Persbericht

21/04 · Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS · Persbericht

21/04 · RAMSAY SANTE : Half-year Financial Report as at end of December 2025 disposal · Persbericht

20/04 · DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call · Persbericht

10/04 · Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year · Persbericht

27/03 · Castle Biosciences' DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026 · Persbericht

24/03 · Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data · Persbericht

18/03 · DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement · Persbericht

16/03 · Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor · Persbericht

Mijn selecties